lifestyle.marketresearchjournals.com

Author: BOSTON SCIENTIFIC CORPORATION

Boston Scientific announces conference call discussing first quarter 2026 results

March 30, 2026
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints

March 28, 2026
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism

March 28, 2026
Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

March 6, 2026
Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

February 23, 2026
Boston Scientific to participate in TD Cowen’s 46th Annual Health Care Conference

February 14, 2026
Boston Scientific announces results for fourth quarter and full year 2025

February 10, 2026
Boston Scientific announces agreement to acquire Penumbra, Inc.

January 15, 2026
Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

January 14, 2026
Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

January 2, 2026